GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » BioLight Life Sciences Ltd (NAS:BOLT) » Definitions » 5-Year Yield-on-Cost %

BioLight Life Sciences (BioLight Life Sciences) 5-Year Yield-on-Cost % : 1.10 (As of Apr. 25, 2024)


View and export this data going back to . Start your Free Trial

What is BioLight Life Sciences 5-Year Yield-on-Cost %?

BioLight Life Sciences's yield on cost for the quarter that ended in Dec. 2023 was 1.10.


The historical rank and industry rank for BioLight Life Sciences's 5-Year Yield-on-Cost % or its related term are showing as below:

BOLT' s 5-Year Yield-on-Cost % Range Over the Past 10 Years
Min: 0   Med: 0   Max: 1.64
Current: 1.1


During the past 12 years, BioLight Life Sciences's highest Yield on Cost was 1.64. The lowest was 0.00. And the median was 0.00.


BOLT's 5-Year Yield-on-Cost % is not ranked
in the Biotechnology industry.
Industry Median: 1.955 vs BOLT: 1.10

Competitive Comparison of BioLight Life Sciences's 5-Year Yield-on-Cost %

For the Biotechnology subindustry, BioLight Life Sciences's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


BioLight Life Sciences's 5-Year Yield-on-Cost % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, BioLight Life Sciences's 5-Year Yield-on-Cost % distribution charts can be found below:

* The bar in red indicates where BioLight Life Sciences's 5-Year Yield-on-Cost % falls into.



BioLight Life Sciences 5-Year Yield-on-Cost % Calculation

Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.

Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.

Therefore, Yield-on-Cost of BioLight Life Sciences is calculated as

Yield-on-Cost=Dividend Yield %*(1+Dividend Growth Rate)^5

BioLight Life Sciences  (NAS:BOLT) 5-Year Yield-on-Cost % Explanation

Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.


BioLight Life Sciences 5-Year Yield-on-Cost % Related Terms

Thank you for viewing the detailed overview of BioLight Life Sciences's 5-Year Yield-on-Cost % provided by GuruFocus.com. Please click on the following links to see related term pages.


BioLight Life Sciences (BioLight Life Sciences) Business Description

Traded in Other Exchanges
Address
Kiryat Atidim, Building 7, Entrance 1, 2nd Floor, Tel-Aviv, ISR, 6158101
BioLight Life Sciences Ltd is an emerging global ophthalmic company. It is engaged in the discovery, development, and commercialization of products and product candidates which address ophthalmic conditions, including glaucoma, dry eye syndrome and age-related macular degeneration. The firm's products include ioptimate, eye-d technology, and diagnostear. The company has the Eye cluster and the Cancer diagnostics cluster operating segments. It derives the majority of its revenues from the Eye cluster segment.

BioLight Life Sciences (BioLight Life Sciences) Headlines

From GuruFocus

Bolt Biotherapeutics Appoints Laura Berner to Board of Directors

By Value_Insider Value_Insider 12-14-2022

Bolt Biotherapeutics to Participate in Upcoming February Conferences

By GuruFocusNews GuruFocusNews 02-02-2022